We are thrilled to announce that Nicolas Cary and Akhilesh K. Sista, MD, FSIR will be our keynote speakers at #SIR24EDGE! Learn more about these two speakers below and register today so you don’t miss these plenary sessions happening Oct. 17–19 in Denver! Nicolas Cary, Co-Founder and Vice Chairman of Blockchain.com, brings a unique perspective to the world of tech and finance with an international upbringing and experience as a teacher in India. Here is what he hopes you take away from his talk: “I hope from the keynote session...SIR EDGE participants can reflect on the emerging opportunities enabled by not just medical breakthroughs, but technological and business practices that can create outside impact for patient results and experiences.” Akhilesh K. Sista, MD, FSIR has given over 140 talks and has been a part of over 80 publications. Here is what he hopes you take away from his session as the Principal Investigator of the PE-TRACT trial funded by the National Institute of Health: “I hope to take the audience on a journey that has culminated in one of the most consequential clinical trials for interventional radiologists in cardiovascular medicine. Listeners will hear about the origins of the PE-TRACT trial and how the need for its execution became stronger even as catheter-directed therapy for pulmonary embolism became more mainstream.” Register today to secure early-bird rates and join us for the first-ever SIR EDGE 2024 meeting: sirweb.link/plenary
Society of Interventional Radiology’s Post
More Relevant Posts
-
🔊 Introducing...The World's First Web3 Radiology Software MVP for Sharing & Storage!! HIPPA, GDPR, CPA, ISO/TC307 compliant. Full DICOM viewer, Physician Dashboard and the 21st Century Benchmark for all Decentralized Facilities. The medical ecosystem grows every year. Where does all that data go? 👏 A BIG Thank you to Daniel Uribe, MBA 🧬🔗🔐 and the whole team at GenoBank.io for making this possible. This has been a research roller-coaster in the making and sometimes the simplest tools are the hardest to make. The engineers put a lot of dedication and time into this. #partnerships #desci 🧙♂️ Human Assets in your own Health Wallet? What?? Step by step, the health care tools in existence will transmogrify before our eyes. The untold stories of our humanity will create a clearer picture when matched with more diagnostic assets. Well on our way to Ancillary 2.0!! 🏆 Microscopy Permission Token! MPT All stakeholders gain incentives from Blockchain consensus. Patients receive their copy of imaging, facilities are compensated and physicians can view assets accumulated from decentralized laboratories, including microscopy. You'd like to use this in your facility or research institute and be involved from the early stages? Contact us! Always looking for more! 🙏 So many thanks to give out and appreciate all the help in getting here. Tory Cenaj Leah Houston, MD Alex Cahana, MD Prof. Dr. Ingrid Vasiliu-Feltes Jeff Blackwood Florence Hudson Benjamin James Humbert Julie Saslow Schroeder, J.D., L.L.M. Mary McCawley Brigitte Piniewski MD Jelani Clarke Ph.D. Erin Zagadailov Nisa Amoils, Esq. Emanuel Mkrtichian Jason Cantu
-
-
When we talk about the intersection of healthcare and innovation, Mazin Gadir PhD MSc BEng PMP Prosci LSSGB EBAS Agile brings his unique expertise. As the Director of Partnerships and Strategic Alliances at IQVIA and a Digital Health Expert at World Health Organization, he brings over 23 years of experience in health informatics, blockchain, and AI-driven solutions. Dr. Gadir, with a PhD in Quantum Electronics and Nanotechnology in Medical Diagnostics, will address key questions about how AI can change medical practices and improve patient care. We are excited to have him at AI Weekend! #AIWeekend #Weekend #WeekendMediaFestival
-
-
How can real-world data (RWD) provide clinical researchers with a fundamental understanding of their trials? Data gathered from the highly controlled environment of a clinical study may not actually depict the “real world” that many patients and care providers will experience. The incorporation of RWD, data gathered from actual patient experiences, in many ways represents an important step toward a fundamentally better understanding of states of disease and health. Biomarkers, electronic health records (EHR), genomic data, imaging data, labs, social media, wearable sensors, and more provide enormous new sources of RWD that can aid in new discoveries for the quality, efficacy, and safety of new drug therapies. Read this MedCity News article to learn how data can improve quality, efficacy, and safety of new drug therapies. https://lnkd.in/eWADVuW4
-
Managing Director at Real Chemistry | Digital Insights and Analytics | Specializing in Pharma + Healthcare
Will you or a colleague be at next week's World Orphan Drug Congress in Boston? Several of my Real Chemistry colleagues will be there, and they'd love to meet up with anyone interested in talking about how advanced analytics and ecosystem-wide thinking can help advance the commercialization of rare disease therapies. Stop by our Real Chemistry booth (#632) for conversation and a chance to win a pair of Bose wireless headsets. Catch my colleagues' keynote panel conversation on Wednesday, April 24: "𝗙𝗿𝗼𝗺 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗳𝗶𝗻𝗱𝗶𝗻𝗴 𝘁𝗼 𝗽𝗮𝘆𝗲𝗿 𝗽𝘂𝗹𝗹-𝘁𝗵𝗿𝗼𝘂𝗴𝗵: 𝗹𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝘁𝗼 𝗳𝘂𝗲𝗹 𝘁𝗵𝗲 𝗿𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻." It should be a great conference! #WorldOrphanUSA #marketaccess #raredisease #RWD #marketresearch #socialintelligence #AI #ML
-
-
🎉 Exciting news from Ironsides Medical! They have been awarded $275,000 by the National Science Foundation (NSF) under the National Science Foundation subagency. This funding will support their groundbreaking project: an AI-powered otoscope for diagnosing ear infections. This innovative device aims to improve diagnostic accuracy from 50-60% to over 92%, reducing antibiotic overprescription and enhancing patient care. #SBIR #STTR #Innovation 🔬 The project, part of the Small Business Innovation Research Program Phase I, will last for 9 months, starting on September 15, 2024, and ending on June 30, 2025. The research will focus on developing a high-resolution camera integrated with advanced machine learning algorithms to guide users in obtaining optimal eardrum views. This award reflects NSF's commitment to supporting impactful research. #Healthcare #AI #MedicalDevices
-
Project "Artificial INTELligence-based Decision Support System for Early and Accurate Diagnosis of HEART Failure" supported by the Science Fund of the Republic of Serbia
🌍 World Heart Day ❤️ Let’s take a moment to reflect on the importance of heart health. Early prevention plays a critical role in combating heart failure. Timely diagnosis can make the difference between managing heart health and facing long-term complications. The INTELHEART project is committed to driving innovation through an AI-powered platform, designed to transform the early diagnosis of heart failure. The INTELHEART platform will uniquely integrate patient-specific data using existing and novel technologies and develop an AI-driven intelligent Decision Support System for patient stratification and heart failure prediction using machine learning, computational modeling, voice characteristics and vocal biomarkers. As we push the boundaries of AI in healthcare, we aim to empower both patients and healthcare providers with tools for more effective, personalized care. Together, let’s reimagine the future of heart health. ❤️ #WorldHeartDay #INTELHEART #fondzanauku #prisma
-
Are you planning attending HIMSS24 - Orlando? Join ACCE on Monday, March 11, for the annual ACCE CE-IT Symposium (pre-HIMSS). The topic in 2024 will be: Implementing Emerging AI Tools and Medical Device Technologies in Healthcare. Register today at https://lnkd.in/gnzECuJa and join our expert speakers who will share their early adopter insights, unveiling the strategies that led to their success, and providing invaluable tips on avoiding common pitfalls. Beyond the technical aspects, we'll also examine AI from a strategic standpoint. How can you develop an AI strategy tailored to your organization's unique needs? How to develop a partnership of Clinical Engineering, IT and Clinical teams in implementing AI Technologies? Is an AI Council necessary to govern these applications effectively? How can you ensure that these technologies and tools yield the maximum value for your organization? Engage in insightful panel discussions with industry leaders representing healthcare organizations, the medical device industry, and researchers. Don't miss this opportunity to stay at the forefront of healthcare's AI revolution! #CE-IT #ACCE #HIMSS24
-
-
Will you or a colleague be at next week's World Orphan Drug Congress in Boston? Several of my Real Chemistry colleagues will be there, and they'd love to meet up with anyone interested in talking about how advanced analytics and ecosystem-wide thinking can help advance the commercialization of rare disease therapies. Stop by our Real Chemistry booth (#632) for conversation and a chance to win a pair of Bose wireless headsets. Catch my colleagues' keynote panel conversation on Wednesday, April 24: "𝗙𝗿𝗼𝗺 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗳𝗶𝗻𝗱𝗶𝗻𝗴 𝘁𝗼 𝗽𝗮𝘆𝗲𝗿 𝗽𝘂𝗹𝗹-𝘁𝗵𝗿𝗼𝘂𝗴𝗵: 𝗹𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝘁𝗼 𝗳𝘂𝗲𝗹 𝘁𝗵𝗲 𝗿𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻." It should be a great conference! #WorldOrphanUSA #marketaccess #raredisease #RWD #marketresearch #socialintelligence #AI #ML
-
-
Will you or a colleague be at next week's World Orphan Drug Congress in Boston? Several of my Real Chemistry colleagues will be there, and they'd love to meet up with anyone interested in talking about how advanced analytics and ecosystem-wide thinking can help advance the commercialization of rare disease therapies. Stop by our Real Chemistry booth (#632) for conversation and a chance to win a pair of Bose wireless headsets. Catch my colleagues' keynote panel conversation on Thursday, April 24: "𝗙𝗿𝗼𝗺 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗳𝗶𝗻𝗱𝗶𝗻𝗴 𝘁𝗼 𝗽𝗮𝘆𝗲𝗿 𝗽𝘂𝗹𝗹-𝘁𝗵𝗿𝗼𝘂𝗴𝗵: 𝗹𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝘁𝗼 𝗳𝘂𝗲𝗹 𝘁𝗵𝗲 𝗿𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻." It should be a great conference! #WorldOrphanUSA #marketaccess #raredisease #RWD #marketresearch #socialintelligence #AI #ML
-
Executive | Clinical, Regulatory Affairs, and Compliance Leader| Artificial Intelligence in Life Sciences Aficionado | Responsible & Effective AI Expert
HeartSciences, has recently been granted a pivotal patent by the European Patent Office for its AI-powered ECG technology! 👏🏻 This patent, covers the use of AI to interpret ECG data for diastolic function— an early indicator of heart disease. For those who don’t know..diastolic dysfunction, which signifies impaired cardiac relaxation, often precedes noticeable symptoms and can be indicative of bunch of different heart conditions. Normally, you’d have to have an echo in a cardiology setting…but this AI-ECG tech integrates the assessment into the ECG, making early detection more accessible, especially for those who may not be at a place where they’re seeing a cardiologist yet…but maybe should be. 🧐 #AI #ECG #CardiacHealth #Innovation #HealthTech #MedicalDevices
UPDATE: HeartSciences just secured a fundamental patent from the European Patent Office (EPO)! It covers using AI-ECG for assessing diastolic function of the heart - crucial for heart screening and early detection of heart disease. The US version has already been granted! #HeartSciences #Innovation $HSCS #NASDAQ #AI #ECG Read more: https://lnkd.in/gHr88qgb.
-
